The roles of STAT5a and ABCB1 in chemoresistance in breast cancer and their regulation were further confirmed by IHC analysis of breast cancer tissues from 67 patients who received DOX-containing neoadjuvant treatment. The gene discussed is STAT5A; the disease is breast carcinoma.